7. Financial performance. Walgreens reported $38.6 billion in sales for the second quarter of fiscal 2025, a 4.1% increase from the same quarter last year. Despite revenue growth, the company posted a $5.6 billion operating loss, largely driven by non-cash impairment charges tied to VillageMD and its retail pharmacy unit. This was an improvement on the $13.2 billion operating loss the company posted in the second quarter last year.